跳至主要内容
临床试验/EUCTR2004-001341-14-IT
EUCTR2004-001341-14-IT进行中(未招募)不适用

Controlled, double-blind, randomized, dose-rangig study of once-daily regimen of BAY 59-7939 in the prevention of VTE in patients undergoing elective total hip replacement - ODIXaHIP-OD study

BAYER0 个研究点目标入组 670 人开始时间: 2008年12月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
BAYER
入组人数
670

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
BAYER

相似试验

进行中(未招募)
1 期
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXa-OD.HIP Study - ODIXa-OD.HIPDeep Venous Thrombosis prophylaxisMedDRA version: 7.0Classification code 10012108
EUCTR2004-001341-14-GBBayer HealthCare AG
进行中(未招募)
不适用
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXaHIP-OD Study - ODIXaHIP-ODDeep Venous Thrombosis prophlaxisMedDRA version: 7.0Classification code 10012108
EUCTR2004-001341-14-ATBayer HealthCare AG670
进行中(未招募)
1 期
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXaHIP-OD Study - ODIXaHIP-OD
EUCTR2004-001341-14-ESBayer HealthCare AG
进行中(未招募)
不适用
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXaHIP-OD Study - ODIXaHIP-ODDeep Venous Thrombosis prophlaxisMedDRA version: 7.0Classification code 10012108
EUCTR2004-001341-14-SEBayer HealthCare AG810
进行中(未招募)
1 期
Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXaHIP-OD Study - ODIXaHIP-ODDeep Venous Thrombosis prophylaxisMedDRA version: 7.0Classification code 10012108
EUCTR2004-001341-14-DKBayer HealthCare AG